Luminex Corporation (LMNX) will start paying a quarterly dividend of $0.06 per share.

This initial cash dividend will be payable on April 14, 2017 to shareholders of record as of the close of business on March 24, 2017.

"Effective capital deployment is an important part of our strategy for creating shareholder value," said Homi Shamir, President and Chief Executive Officer of Luminex Corporation. "Acquisitions have been an important part of our strategy and we will continue to pursue opportunities that generate sustainable growth.  Today's actions reflect our confidence in the Company's strategy, and are a result of our strong operating results in 2016 and our 2017 outlook that includes an attractive pipeline of innovative technology, and continued solid financial performance with continued strong cash flow generation.  I am delighted to make this announcement for our shareholders and am confident that we are retaining the flexibility to pursue future strategic opportunities."

Luminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries.